Personal information

Verified email domains

cancer, oncology, Pancreas cancer, bladder cancer, molecular pathology, cell differentiation, cancer genetics
Spain

Biography

I trained as a medical oncologist at Memorial Hospital, New York, where he also carried out research on tumor immunology (1981-1986). After 2 years as a Memorial Hospital staff physician, I returned to IMIM, Barcelona, where I set up from scratch a new research programme in cancer cell and molecular biology (1988). Together with other colleagues, I played a key role in the growth of IMIM and in the establishment of the Department of Experimental and Health Sciences, Universitat Pompeu Fabra (from 1997 on). In 2003, I became Professor of Cell Biology at UPF where I continue to teach in the undergraduate and graduate programmes. In late 2007 I joined the CNIO where I am Senior Group Leader (Epithelial Carcinogenesis Group).
In the last 15 years, our laboratory has focused on the study of the cell and molecular biology of pancreatic and bladder cancer. Because the challenges posed by these two tumor types are very different, our approaches to them are also different. In pancreatic cancer, we focus on the identification of early mechanisms that favour tumor development. These studies are not possible in humans, therefore we use genetic mouse models and we hope that they will guide us to develop better strategies for identification of subjects at risk of pancreatic cancer. As of bladder cancer, we have as a major aim to understand better the genetic pathways leading to the various bladder cancer subtypes. For this, we combine the use of state-of-the art genetic tools (whole exome and whole genome sequencing) with the establishment of large patient cohorts that allow us to test the translational potential of our findings. We have a major interest in developing (and replicating) tools for improved treatment of patients with muscle-invasive tumors.
We have established a wide network of collaborators in both areas and are well recognized at the international level. We participate in several European and worldwide consortia and have published in some of the best journals either as leaders or through collaboration.

Activities

Employment (1)

CNIO: Madrid, Madrid, ES

2007 to present | Senior Group Leader (Epithelial Carcinogenesis Group)
Employment
Source: Self-asserted source
Francisco X Real

Education and qualifications (2)

Universitat Autònoma de Barcelona: Bellaterra, Catalunya, ES

1986 | Doctor en Medicina
Education
Source: Self-asserted source
Francisco X Real

Universitat Autònoma de Barcelona: Bellaterra, Catalunya, ES

1980 | Licenciado en Medicina
Education
Source: Self-asserted source
Francisco X Real

Funding (15)

STAG2 and FGFR3: cooperation with the DREAM complex in bladder cancer

2022-12 to 2025-11 | Grant
Fundación Científica AECC (Madrid, ES)
GRANT_NUMBER:

PRYGN223005REAL

Source: Self-asserted source
Francisco X Real

Role of the smooth muscle layer in bladder cancer biology and progression: a systems and experimental approach

2022-12 to 2024-08 | Grant
US National Institute of Health (NIH) (Bethesda, US)
GRANT_NUMBER:

R21CA266660

Source: Self-asserted source
Francisco X Real

METneural: Crosstalk between brain metastasis and neural circuits

2022-09 to 2025-08 | Grant
Proyectos de la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

PID2021-128125OB-I00

Source: Self-asserted source
Francisco X Real

PDAC-MolPrev: An integrative approach towards the prevention of pancreatic cancer using mouse models and genomic tools

2022-09 to 2025-08 | Grant
Agencia Estatal de Investigación (Madrid, ES)
GRANT_NUMBER:

PID2021-128125OB-I00

Source: Self-asserted source
Francisco X Real

Dinámicas de competición celular y evolución clonal durante regeneración y carcinogénesis en el urotelio

2021-09 to 2024-08 | Grant
Ministerio de Ciencia y Tecnología (Madrid, ES)
GRANT_NUMBER:

PID2020-116163GA-I00

Source: Self-asserted source
Francisco X Real

RBM10, a novel splicing regulator and tumor suppressor: from mechanisms to therapies

2021-01 to 2025-06 | Grant
La Caixa Foundation (Valencia, ES)
GRANT_NUMBER:

HR21-01208

Source: Self-asserted source
Francisco X Real

Tumor Microbiome and Immune profiles as predictors of treatment response in high-risk non-muscle invasive bladder cancer

2021-01 to 2023-12 | Grant
Fundación Ramón Areces-CNIO-Weizmann Institute of Science (-, ES)
Source: Self-asserted source
Francisco X Real

Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer

2020-09 to 2022-08 | Grant
EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions (Brussels, BE)
GRANT_NUMBER: 895943
Source: check_circle
CIÊNCIAVITAE

Transys: Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine

2019-09 to 2024-08 | Grant
Horizon 2020 Framework Programme (nf, BE)
GRANT_NUMBER:

GA 860895

Source: Self-asserted source
Francisco X Real

Transcription factors in pancreatic cancer: from biology to therapy

2019-01 to 2022-08 | Grant
Ministerio de Ciencia. Innovación y Universidades-FEDER (Madrid, ES)
GRANT_NUMBER:

RTI2018-101071-B-I00

Source: Self-asserted source
Francisco X Real

Desarrollo preclínico de anticuerpos inmunomoduladores anti-PD-L2 para el tratamiento de patologías inducidas por daño celular - validación de la estrategia en tumores residuales y en fibrosis

2018-12 to 2021-06 | Grant
Retos-Colaboración, Ministerio de Universidades, Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

RTC-2017-6123-1

Source: Self-asserted source
Francisco X Real

CB16/12/00453

2017 to 2018 | Grant
CIBER (Madrid, Madrid, ES)
GRANT_NUMBER:

CB16/12/00453

Source: Self-asserted source
Francisco X Real

Cancer de vejiga invasivo: hacia una medicina de precision. Asociacion Espanola Contra el Cancer

2014-09 to 2021-12 | Grant
Asociación Española Contra el Cáncer (Madrid, Madrid, ES)
GRANT_NUMBER:

AECC-Coord2014

Source: Self-asserted source
Francisco X Real

Control transcripcional de la diferenciación de las células acinares y cáncer de páncreas.

2012 to 2014 | Grant
Plan Nacional de I+D+I, Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

SAF2011-29530

Source: Self-asserted source
Francisco X Real

Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumors. 7th Framework EU programme.

2011-04 to 2014-09 | Grant
CANCERALIA (Madrid, ES)
Source: Self-asserted source
Francisco X Real